CMC(SH:603122) 2 1 Shi Ji Jing Ji Bao Dao·2025-11-20 06:03Core Viewpoint - The stock of HeFu China (603122.SH) has experienced significant volatility, with a remarkable increase of 291.92% over 15 trading days, raising concerns about the disconnect between its stock price and fundamental performance [1][2][3] Group 1: Stock Performance - HeFu China's stock price reached a limit-up of 26.18 CNY per share, with a trading volume of 0.85 billion CNY at midday on November 20 [1] - The stock has achieved 13 limit-up days since October 28, with 12 out of 14 trading days experiencing limit-up conditions [1] - The stock's turnover rate peaked at 28.48% on November 14, indicating high trading activity [1] Group 2: Financial Performance - For the first three quarters of 2023, HeFu China reported a revenue of 549 million CNY, a year-on-year decline of 22.8% [2] - The company incurred a net loss of 12.39 million CNY, a significant drop of 146.65% compared to the previous year [2] - The decline in performance is attributed to changes in the domestic macroeconomic environment and price reductions in the medical industry due to centralized procurement policies [2] Group 3: Regulatory Attention - The unusual trading behavior of HeFu China has attracted the attention of regulatory authorities, with the Shanghai Stock Exchange indicating stricter scrutiny of its trading activities [3] - The company has issued warnings about the risks associated with its stock price volatility, emphasizing that its main business has not undergone significant changes and it remains in a loss position [3] - Regulatory measures may include stricter monitoring and potential trading restrictions for accounts involved in the unusual trading [3]